当少不多时:探索当前证据,实践和关于心力衰竭患者流体限制的观点
Siddharth Pravin Agrawal1, Darshilkumar Maheta2, Rushin S Shah3
1From the Department of Medicine, New York Medical College/Landmark Medical Center, Woonsocket, RI.
Cardiology in review
|September 19, 2025
概括
在心力衰竭 (HF) 管理中,严格的液体限制可能提供有限的益处,并对生活质量产生负面影响. 自由的,以口渴为导向的方法是安全的,并提高了患者的舒适性,挑战了传统的做法.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内部医学 内部医学
背景情况:
- 限制流体是管理心力衰竭 (HF) 的传统基石,旨在防止体积过载.
- 这种基于生理学理由的做法缺乏强有力的临床证据,并引起了对患者生活质量和脱水风险的担忧.
研究的目的:
- 审查流体限制在慢性HF管理中的演变作用.
- 为了平衡生理学逻辑与以患者为中心的结果,并评估当前的证据.
主要方法:
- 历史实践和关键临床试验的叙述性审查,包括FRESH-UP试验.
- 批判性检查与HF患者的液体过载和脱水相关的风险.
主要成果:
- 支持HF常规流体限制的证据有限且不一致.
- FRESH-UP试验表明,自由的,以口渴为导向的液体摄入是安全的,可以减少口渴的痛苦,没有不良的临床结果.
- 严格的液体限制对大多数稳定的慢性HF患者提供了最小的益处.
结论:
- 新出现的证据挑战了在高频中严格限制流体的普遍应用.
- 一个个性化的,自由的流体管理方法可以提高患者的舒适性和生活质量,而不会影响安全.
- 这一转变反映了心力衰竭护理的不断发展,以患者为中心的方向.
相关概念视频
Heart Failure VI: Adjunct Therapies
261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261
Heart Failure Drugs: Diuretics
809
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
809
Heart Failure VII: Nursing Interventions
422
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
422
Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
Mitral Regurgitation IV: Nursing Management
311
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
311
Heart Failure II: Pathophysiology
734
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
734


